Literature DB >> 29550804

Autologous cord blood transfusion in preterm infants - could its humoral effect be the kez to control prematurity-related complications? A preliminary study.

M Kotowski1, Z Litwinska1, P Klos1, E Pius-Sadowska1, E Zagrodnik-Ulan2, P Ustianowski3, J Rudnicki4, B Machalinski5.   

Abstract

Umbilical cord blood (UCB), rich in stem/progenitor cells, is partially eliminated from the bloodstream during childbirth because the cord is immediately clamped. We hypothesize that transfusion of autologous UCB to premature infants after delivery could serve as an adjuvant modality for preventing the development of prematurity-related complications. We randomly enrolled 20 preterm infants born before 32 weeks of gestational age (GA), all of whom developed anemia, necessitating transfusion of red blood cells (RBCs). Two groups, matched for GA, were selected: (1) infants (n = 5) who underwent UCB transfusion once within 5 days of birth (mean ± standard deviation, 3.2 ± 1.9 days) and (2) infants (n = 15) from whom UCB was not collected (e.g., lack of consent). The latter served as controls and received allogeneic RBC transfusions (7.8 ± 3.9 days after birth). Selected prematurity-related complications were monitored. Two weeks after UCB/RBC transfusion, peripheral blood samples were collected, and the concentrations of 41 selected growth factors and their receptors were analyzed using a multiplex protein array. UCB transfusions were found to be both feasible and tolerable. Intraventricular haemorrhage was diagnosed in two of five (40%) UCB recipients, but was found in thirteen of fifteen RBC recipients (86.7%). Twenty-two plasma proteins (e.g., insulin-like growth factors, stem cell factor, epidermal growth factors) were found with significantly different concentrations in UCB recipients compared to controls. Results demonstrate safety and feasibility of UCB transfusion in a small group of very premature neonates and should be interpreted as preliminary speculation. Transfusion of UCB could induce a specific humoral effects, and this could serve as an adjuvant modality for prevention of prematurity complications.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29550804

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  9 in total

Review 1.  Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy.

Authors:  Izabela Zdolińska-Malinowska; Dariusz Boruczkowski; Dominika Hołowaty; Paweł Krajewski; Emilian Snarski
Journal:  Stem Cells Int       Date:  2022-05-11       Impact factor: 5.131

2.  Stem cell-based interventions for the prevention and treatment of germinal matrix-intraventricular haemorrhage in preterm infants.

Authors:  Olga Romantsik; Matteo Bruschettini; Alvaro Moreira; Bernard Thébaud; David Ley
Journal:  Cochrane Database Syst Rev       Date:  2019-09-24

3.  Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation.

Authors:  Maria Bianchi; Nicoletta Orlando; Ombretta Barbagallo; Sabrina Sparnacci; Caterina Giovanna Valentini; Brigida Carducci; Luciana Teofili
Journal:  Blood Transfus       Date:  2020-11-03       Impact factor: 3.443

4.  Feasibility of umbilical cord blood as a source of red blood cell transfusion in preterm infants.

Authors:  Elsa García González; Miguel Alsina Casanova; Dinara Samarkanova; Victoria Aldecoa-Bilbao; Marta Teresa-Palacio; Elisenda Farssac Busquets; Josep Figueras-Aloy; MªDolors Salvia-Roigés; Sergi Querol
Journal:  Blood Transfus       Date:  2020-12-18       Impact factor: 3.443

5.  Use of Autologous Cord Blood Mononuclear Cells Infusion for the Prevention of Bronchopulmonary Dysplasia in Extremely Preterm Neonates: A Study Protocol for a Placebo-Controlled Randomized Multicenter Trial [NCT03053076].

Authors:  Zhuxiao Ren; Xu Fang; Qi Zhang; Y G Mai; X Y Tang; Q Q Wang; C H Lai; W H Mo; Y H Dai; Q Meng; Jing Wu; Z Z Ao; H Q Jiang; Yong Yang; L H Qu; C B Deng; Wei Wei; Yongsheng Li; Q I Wang; Jie Yang
Journal:  Front Pediatr       Date:  2020-04-02       Impact factor: 3.418

6.  Autologous cord blood cell infusion in preterm neonates safely reduces respiratory support duration and potentially preterm complications.

Authors:  Zhuxiao Ren; Fang Xu; Xiaoling Zhang; Chunyi Zhang; Jiayu Miao; Xin Xia; Mengmeng Kang; Wei Wei; Tianbao Ma; Qi Zhang; Lijuan Lu; Jiying Wen; Guocheng Liu; Kaiyan Liu; Qi Wang; Jie Yang
Journal:  Stem Cells Transl Med       Date:  2019-11-08       Impact factor: 6.940

7.  Safety of Autologous Cord Blood Cells for Preterms: A Descriptive Study.

Authors:  Jie Yang; Zhuxiao Ren; Chunyi Zhang; Yunbei Rao; Junjuan Zhong; Zhu Wang; Zhipeng Liu; Wei Wei; Lijuang Lu; Jiying Wen; Guocheng Liu; Kaiyan Liu; Qi Wang
Journal:  Stem Cells Int       Date:  2018-08-15       Impact factor: 5.443

8.  Effect of red blood cell transfusion on the development of retinopathy of prematurity: A systematic review and meta-analysis.

Authors:  Zhe Zhu; Xin Hua; Yong Yu; Pan Zhu; Kairui Hong; Yefang Ke
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

Review 9.  Recent advances in perinatal neuroprotection.

Authors:  Samata Singhi; Michael Johnston
Journal:  F1000Res       Date:  2019-11-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.